Home600812 • SHA
North China Pharmaceutical Co Ltd
¥5.14
Sep 27, 4:00:03 PM GMT+8 · CNY · SHA · Disclaimer
Stock
Previous close
¥4.97
Day range
¥5.04 - ¥5.15
Year range
¥3.83 - ¥6.66
Avg Volume
8.37M
P/E ratio
175.19
Dividend yield
0.19%
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
(CNY)Jun 2024Y/Y change
Revenue
2.67B3.90%
Operating expense
619.68M-8.97%
Net income
53.83M154.82%
Net profit margin
2.01145.12%
Earnings per share
EBITDA
357.94M23.27%
Effective tax rate
29.66%
Total assets
Total liabilities
(CNY)Jun 2024Y/Y change
Cash and short-term investments
1.77B27.54%
Total assets
21.75B3.02%
Total liabilities
15.20B2.28%
Total equity
6.55B
Shares outstanding
1.72B
Price to book
1.60
Return on assets
1.97%
Return on capital
2.38%
Net change in cash
(CNY)Jun 2024Y/Y change
Net income
53.83M154.82%
Cash from operations
316.10M309.85%
Cash from investing
-134.74M3.73%
Cash from financing
845.54M325.07%
Net change in cash
1.03B340.40%
Free cash flow
511.61M301.13%
About
North China Pharmaceutical Group Corp., is a pharmaceutical manufacturer in China. NCPC was one of the key construction projects during China's First Five-Year Plan. After five years of construction since the foundation date in June 1953, the first successful pharmaceutical production, started in June 1958. Being one of the antibiotic producers both in technology and production scale at that time, NCPC created a history of commercial production of antibiotics in China. It has 45 years of development experience. NCPC has been taking the lead in the Chinese pharmaceutical industry in key economic indexes, ranked as one of the Top500 Enterprises and the best profit-makers in China. By the end of 2002, the total assets of the company were valued at US$2 billion, with 18,500 employees. In 2002, NCPC claimed a domestic sales revenue of US$700 million and export sales of US$100 million. Wikipedia
Founded
Dec 20, 1992
Employees
10,159
Search
Clear search
Close search
Google apps
Main menu